Cargando…

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

INTRODUCTION: Macrophage activation syndrome (MAS), a secondary form of hemophagocytic lymphohistiocytosis, is a serious life-threatening complication associated with systemic juvenile idiopathic arthritis (sJIA). MAS is characterized by fever, hepatosplenomegaly, liver dysfunction, cytopenias, coag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chellapandian, Deepak, Milojevic, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986425/ https://www.ncbi.nlm.nih.gov/pubmed/36891226 http://dx.doi.org/10.3389/fped.2023.1123104

Ejemplares similares

Efficacy and safety of emapalumab in macrophage activation syndrome
por: De Benedetti, Fabrizio, et al.
Publicado: (2023)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS)
por: Cortes, Marianne, et al.
Publicado: (2023)

Management of Hepatitis A-induced Macrophage Activation Syndrome With Anakinra in Systemic Juvenile Idiopathic Arthritis: A Case Report
por: AlNouwaiser, Deena N, et al.
Publicado: (2022)

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
por: Schuelke, Matthew R., et al.
Publicado: (2023)

Isolated Facet Joint Arthritis in Juvenile Idiopathic Arthritis
por: Martone, Giulia, et al.
Publicado: (2021)

JAK inhibitors in systemic juvenile idiopathic arthritis
por: He, Tingyan, et al.
Publicado: (2023)

Refractory systemic juvenile idiopathic arthritis complicated by coxarthrosis
por: Mellos, Antonio, et al.
Publicado: (2014)

Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
por: Davidson, Nicole, et al.
Publicado: (2021)

Wilson’s Disease Masquerading as Juvenile Idiopathic Arthritis in an Adolescent
por: Goyal, Rajeev, et al.
Publicado: (2020)

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results
por: Brunner, Hermine I., et al.
Publicado: (2020)

Application of Intra-articular Corticosteroid Injection in Juvenile Idiopathic Arthritis
por: Li, Sha, et al.
Publicado: (2022)

The Importance of Differentiating Oligoarticular Juvenile Idiopathic Arthritis From Lyme Arthritis in Pediatric Patients
por: Jeelani, Wajiha, et al.
Publicado: (2022)

Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis
por: Jain, Deepak, et al.
Publicado: (2016)

Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum
por: Go, Ellen, et al.
Publicado: (2021)

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis
por: Golhen, Klervi, et al.
Publicado: (2022)

Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis
por: Arve-Butler, Sabine, et al.
Publicado: (2023)

The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis
por: Eng, Simon W M, et al.
Publicado: (2014)

Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Minoia, Francesca, et al.
Publicado: (2014)

Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study
por: Tappeiner, Christoph, et al.
Publicado: (2018)

Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2020)

A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs
por: Shen, Biyu, et al.
Publicado: (2022)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005–2021)
por: Foley, C. M., et al.
Publicado: (2023)

Validity and Reliability of Four Parent/Patient–Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
por: van Dijkhuizen, E. H. Pieter, et al.
Publicado: (2022)

Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis
por: Resnick, Cory M., et al.
Publicado: (2016)

Secukinumab Therapy in Refractory Juvenile Idiopathic Arthritis
por: Nelson, Meghan Corrigan, et al.
Publicado: (2023)

Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan
por: Kanemasa, Hikaru, et al.
Publicado: (2021)

Association of Anxiety With Pain and Disability but Not With Increased Measures of Inflammation in Adolescent Patients With Juvenile Idiopathic Arthritis
por: Hanns, Laura, et al.
Publicado: (2020)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
por: Shimizu, Masaki, et al.
Publicado: (2020)

Arthritis in Two Patients With Partial Recombination Activating Gene Deficiency
por: Wu, Kevin Y., et al.
Publicado: (2019)

Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)
por: Merli, Pietro, et al.
Publicado: (2020)

Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
por: Inoue, Natsumi, et al.
Publicado: (2023)

Tumefactive synovial thickening mimicking synovial chondromatosis in the setting of oligoarticular juvenile idiopathic arthritis in a toddler
por: Rousslang, Lee K., et al.
Publicado: (2019)

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease
por: Yan, Xin, et al.
Publicado: (2021)

Peripheral Blood Lymphocyte Analysis in Oligo- and Polyarticular Juvenile Idiopathic Arthritis Patients Receiving Methotrexate or Adalimumab Therapy: A Cross-Sectional Study
por: Nagy, Arnold, et al.
Publicado: (2020)

Persistent Tenosynovitis, Steroid Dependency and a Hyperpigmented Scaly Macular Rash in a Child With Juvenile Idiopathic Arthritis
por: Papatesta, Eleni Maria, et al.
Publicado: (2020)

Multicentric Carpo-Tarsal Osteolysis Syndrome Mimicking Juvenile Idiopathic Arthritis: Two Case Reports and Review of the Literature
por: Wu, Junfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_psufebn80nvi7h2ou03sci9kng